Researchers from Tel Aviv University and the Israel Institute for Biological Research develop an mRNA-based vaccine against a deadly bacterium
Peer-Reviewed Publication
Updates every hour. Last Updated: 20-Oct-2025 20:11 ET (21-Oct-2025 00:11 GMT/UTC)
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform developed for COVID-19 vaccines to create the world’s first mRNA-based vaccine against a deadly, antibiotic-resistant bacterium. In this groundbreaking study, the researchers tested the vaccine’s resistance to the virulent pathogen that causes the disease and were able to demonstrate 100% protection against infection in animal models. The researchers now hope that this technology can be used to combat other lethal bacteria as well.
By analyzing data on the genetics and reported traits of more than 5,000 individuals with autism, researchers at the Flatiron Institute’s Center for Computational Biology and Princeton University have identified four classes for which observable characteristics correlate with genetic variants and related biological processes. The results could have implications for understanding different types of autism and developing more personalized support, such as counseling and physical therapy.
Researchers have identified four clinically and biologically distinct subtypes of autism, marking a transformative step in understanding the condition’s genetic underpinnings and potential for personalized care.
Research into the intestinal cells of Burmese pythons has revealed the existence of a previously unknown cell type, responsible for completely absorbing the skeletons of their prey.